These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9229581)

  • 1. Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage.
    Awad JA; Roberts LJ; Burk RF; Morrow JD
    Gastroenterol Clin North Am; 1996 Jun; 25(2):409-27. PubMed ID: 9229581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isoprostanes: their quantification as an index of oxidant stress status in vivo.
    Morrow JD
    Drug Metab Rev; 2000; 32(3-4):377-85. PubMed ID: 11139135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; Nüsing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
    Morrow JD; Awad JA; Boss HJ; Blair IA; Roberts LJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10721-5. PubMed ID: 1438268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients.
    Basu S
    Toxicology; 2003 Jul; 189(1-2):113-27. PubMed ID: 12821287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release.
    Jourdan KB; Evans TW; Goldstraw P; Mitchell JA
    FASEB J; 1999 Jun; 13(9):1025-30. PubMed ID: 10336884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies.
    Minghetti L; Greco A; Cardone F; Puopolo M; Ladogana A; Almonti S; Cunningham C; Perry VH; Pocchiari M; Levi G
    J Neuropathol Exp Neurol; 2000 Oct; 59(10):866-71. PubMed ID: 11079776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
    Roberts LJ; Morrow JD
    Ann N Y Acad Sci; 1994 Nov; 744():237-42. PubMed ID: 7825845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
    Greco A; Minghetti L
    Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation.
    Morrow JD; Awad JA; Kato T; Takahashi K; Badr KF; Roberts LJ; Burk RF
    J Clin Invest; 1992 Dec; 90(6):2502-7. PubMed ID: 1469101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
    Lynch SM; Morrow JD; Roberts LJ; Frei B
    J Clin Invest; 1994 Mar; 93(3):998-1004. PubMed ID: 8132786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
    Morrow JD; Hill KE; Burk RF; Nammour TM; Badr KF; Roberts LJ
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9383-7. PubMed ID: 2123555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes.
    Longmire AW; Swift LL; Roberts LJ; Awad JA; Burk RF; Morrow JD
    Biochem Pharmacol; 1994 Mar; 47(7):1173-7. PubMed ID: 8161346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
    Yin H; Gao L; Tai HH; Murphey LJ; Porter NA; Morrow JD
    J Biol Chem; 2007 Jan; 282(1):329-36. PubMed ID: 17107953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases.
    Klein T; Reutter F; Schweer H; Seyberth HW; Nüsing RM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1658-65. PubMed ID: 9316884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.
    Greco A; Minghetti L; Levi G
    Neurochem Res; 2000 Oct; 25(9-10):1357-64. PubMed ID: 11059806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma.
    Awad JA; Morrow JD; Takahashi K; Roberts LJ
    J Biol Chem; 1993 Feb; 268(6):4161-9. PubMed ID: 8440704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.